1. 1) Ferrero-Miliani, L., Nielsen, O. H., Andersen, P. S. and Girardin, S. E. (2007) Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin. Exp. Immunol., 147, 227-235.
2. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract the double-edged sword
3. 3) Patino, F. G., Olivieri, J., Allison, J. J., Mikuls, T. R., Moreland, L., Kovac, S. H., Juarez, L., Person, S., Curtis, J. and Saag, K. G. (2003) Nonsteroidal antiinflammatory drug toxicity monitoring and safety practices. J. Rheumatol., 30, 2680-2688.
4. 4) Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., Burr, A. M., Zhao, W. W., Kent, J. D., Lefkowith, J. B., Verburg, K. M. and Geis, G. S. (2000) Gastrointestinal toxicity with celecoxib vs non steroidal antiinfammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized control trial. Celecoxib long-term arthritis safety study. J. Am. Med. Assoc., 284, 1247-1255.
5. 5) Solomon, D. H., Schneeweiss, S., Glynn, R. J., Kiyota, Y., Levin, R., Mogun, H. and Avorn, J. (2004) Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation, 109, 2068-2073.